tiprankstipranks
Trending News
More News >
Advertisement
Advertisement

Shanghai Kindly Medical Instruments Announces H1 2025 Financial Results

Story Highlights
  • Shanghai Kindly Medical Instruments will disclose its financial performance for H1 2025.
  • The company reported a net profit of RMB 102.44 million and total assets of RMB 2.88 billion.
  • Looking for the best stocks to buy? Follow the recommendations of top-performing analysts.
Shanghai Kindly Medical Instruments Announces H1 2025 Financial Results

Elevate Your Investing Strategy:

  • Take advantage of TipRanks Premium at 50% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence.

Shanghai Kindly Medical Instruments Co., Ltd. Class H ( (HK:1501) ) has shared an update.

Shanghai Kindly Medical Instruments Co., Ltd., a joint stock company incorporated in China, is set to disclose its financial performance for the first half of 2025. The announcement reveals that the company, with a significant equity interest held by Shanghai Kindly Enterprise Development Group Co., Ltd., reported a net profit of RMB 102.44 million and total assets amounting to RMB 2.88 billion. This disclosure aims to ensure transparency and equal access to financial information for all shareholders, reflecting the company’s commitment to maintaining robust communication with its stakeholders.

The most recent analyst rating on (HK:1501) stock is a Buy with a HK$37.00 price target. To see the full list of analyst forecasts on Shanghai Kindly Medical Instruments Co., Ltd. Class H stock, see the HK:1501 Stock Forecast page.

More about Shanghai Kindly Medical Instruments Co., Ltd. Class H

Average Trading Volume: 38,015

Technical Sentiment Signal: Buy

Current Market Cap: HK$5.9B

See more data about 1501 stock on TipRanks’ Stock Analysis page.

Disclaimer & DisclosureReport an Issue

Looking for investment ideas? Subscribe to our Smart Investor newsletter for weekly expert stock picks!
Get real-time notifications on news & analysis, curated for your stock watchlist. Download the TipRanks app today! Get the App
1